Barbara Pistilli

46PUBLICATIONS
246CO-AUTHORS
Molecular targetsPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Oct 09, 2026
A modular framework for antibody-drug conjugate biomarkers.

|Jul 29, 2026
Maternal and Neonatal Complications Associated with Breast Cancer Systemic Treatments-A VigiBase Disproportionality Analysis Study.

|Mar 09, 2026
VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer.

Sara A Hurvitz, Rachel M Layman, Giuseppe Curigliano

|Jan 21, 2026
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer.

Sara M Tolaney, Evandro de Azambuja, Kevin Kalinsky

|Dec 29, 2025
OPERA-01: a phase III study of palazestrant for ER+, HER2- advanced breast cancer after CDK4/6 inhibitor therapy.

Barbara Pistilli, Meritxell Bellet Ezquerra, Lucia Del Mastro

|Dec 15, 2025
Patritumab deruxtecan in breast cancer treatment: a drug evaluation.

Adina Sabau, Jessica Paparo, Rasha Cheikh-Hussin

Pageof 8

Frequent Collaborators

13 joint publications

Fabrice André

13 joint publications

Ines Vaz-Luis

12 joint publications

Antonio Di Meglio

10 joint publications

Suzette Delaloge